Vyvgart is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Vyvgart is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameVyvgart
Authorized genericefgartigimod alfa
Regular genericefgartigimod alfa
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Vyvgart?
The original
–
–

Brand nameThe maker’s card

My VYVGART Path Co-pay Program

Savings card from argenx

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a year

The card takes up to $25,000 a year off your co-pay.

Sign up on vyvgart.com 

Or call 1-833-898-4278.

In the maker’s words

“Eligible commercially insured patients may pay as little as $0 for VYVGART and may receive a maximum benefit of $25,000 per calendar year for their eligible out-of-pocket costs for the drug and drug administration.”

From the maker’s offer on vyvgart.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Vyvgart itself, from the same company, sold without the brand name, and usually for less. For now Vyvgart is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Vyvgart is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VYVGART is a neonatal Fc receptor blocker indicated for the treatment of adult patients with generalized myasthenia gravis (gMG).

Source: the FDA label for Vyvgart (argenx US), May 13, 2026. Full label on DailyMed 

Good to know